Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators.

Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL.

J Am Coll Cardiol. 2000 Jan;35(1):183-7.

2.

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P.

Circulation. 2004 Oct 19;110(16):2287-92. Epub 2004 Oct 11.

3.

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ; ACTIVE W Investigators.

J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. Epub 2007 Nov 13.

6.

Newly detected atrial fibrillation and compliance with antithrombotic guidelines.

Glazer NL, Dublin S, Smith NL, French B, Jackson LA, Hrachovec JB, Siscovick DS, Psaty BM, Heckbert SR.

Arch Intern Med. 2007 Feb 12;167(3):246-52.

PMID:
17296879
7.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
8.

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M; AFFIRM Investigators.

Am Heart J. 2005 Apr;149(4):650-6.

PMID:
15990748
9.

Guidelines for stroke prevention in patients with atrial fibrillation.

Howard PA.

Drugs. 1999 Dec;58(6):997-1009. Review.

PMID:
10651387
10.

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators.

Am Heart J. 2006 Nov;152(5):967-73.

PMID:
17070169
11.
12.

Prevention of stroke in patients with nonvalvular atrial fibrillation.

Hart RG, Sherman DG, Easton JD, Cairns JA.

Neurology. 1998 Sep;51(3):674-81. Review.

PMID:
9748009
13.

Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.

Lip GY, Frison L, Grind M; SPORTIF Investigators.

J Intern Med. 2008 Jul;264(1):50-61. doi: 10.1111/j.1365-2796.2007.01909.x. Epub 2008 Feb 4.

14.
15.

Atrial fibrillation in older stroke patients: association with recurrence and mortality after first ischemic stroke.

Kaarisalo MM, Immonen-Räihä P, Marttila RJ, Lehtonen A, Salomaa V, Sarti C, Sivenius J, Torppa J, Tuomilehto J.

J Am Geriatr Soc. 1997 Nov;45(11):1297-301.

PMID:
9361653
16.

[Atrial fibrillation and thromboembolic events prevention. State of the art].

Matteoli S, Trappolini M, Chillotti FM.

Minerva Cardioangiol. 2001 Feb;49(1):1-13. Review. Italian.

PMID:
11279381
17.
18.

Stroke Prevention in Atrial Fibrillation Study. Final results.

[No authors listed]

Circulation. 1991 Aug;84(2):527-39.

PMID:
1860198
19.

Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.

Tsivgoulis G, Spengos K, Zakopoulos N, Manios E, Peppes V, Vemmos K.

Age Ageing. 2005 Jan;34(1):35-40.

PMID:
15591481
20.

Anticoagulation influences long-term outcome in patients with nonvalvular atrial fibrillation and severe ischemic stroke.

Vemmos KN, Tsivgoulis G, Spengos K, Manios E, Toumanidis S, Zakopoulos N, Moulopoulos SD.

Am J Geriatr Pharmacother. 2004 Dec;2(4):265-73.

PMID:
15903285

Supplemental Content

Support Center